Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01811342 · ClinicalTrials.gov registry record

Continuous Hemoglobin Evaluation

A clinical trial, sponsored by University of California, Davis.

Completed
Registry status
70
Enrollment target

NCT01811342: Completed study, sponsored by University of California, Davis.

NCT01811342 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01811342 has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
70 participants
Enrollment target

Study Summary

Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.

Primary Outcome

Determine the influence of initial calibration and intraoperative oxygenation variables on the correlation between SpHgb and clinical values

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2012-11
Est. Completion 2015-09
University of California, Davis

657 total trials

What the finished NCT01811342 record still lists

NCT01811342 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01811342 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01811342 about?

NCT01811342 is a clinical study titled "Continuous Hemoglobin Evaluation". Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.

What is the current status of trial NCT01811342?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-11. Estimated completion is 2015-09.

Who is sponsoring clinical trial NCT01811342?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01811342, the US trial registry maintained by the National Library of Medicine. NCT01811342 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.